---
title: "Raytron's thermal camera now in 20+ vehicle models to improve night driving safety with sensor fusion."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274267402.md"
description: "On January 30, 2026, in Las Vegas, Raytron, a prominent company specializing in infrared thermal imaging, revealed a shift in automotive perception architectures due to increased dangers associated with driving in darkness, low-visibility scenarios, and harsh weather conditions. Moving away from relying solely on \"single sensor\" systems, the industry is adapting to a more advanced approach known as \"sensor fusion\". This advancement aims to enhance safety by combining multiple sensors for a comprehensive data analysis."
datetime: "2026-01-30T07:25:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274267402.md)
  - [en](https://longbridge.com/en/news/274267402.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274267402.md)
generator: "portal-rs"
---

# Raytron's thermal camera now in 20+ vehicle models to improve night driving safety with sensor fusion.

On January 30, 2026, in Las Vegas, Raytron, a prominent company specializing in infrared thermal imaging, revealed a shift in automotive perception architectures due to increased dangers associated with driving in darkness, low-visibility scenarios, and harsh weather conditions. Moving away from relying solely on "single sensor" systems, the industry is adapting to a more advanced approach known as "sensor fusion". This advancement aims to enhance safety by combining multiple sensors for a comprehensive data analysis.

### Related Stocks

- [688002.CN](https://longbridge.com/en/quote/688002.CN.md)

## Related News & Research

- [Nasdaq Futures Plunge as Rising Bond Yields Drive Chip Selloff](https://longbridge.com/en/news/296216952.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [Ata Turizm Discloses High Non-Compliant Income Under Participation Finance Rules](https://longbridge.com/en/news/296522750.md)
- [XSpray Pharma receives FDA complete response letter for Dasynoc over GMP issues at contract manufacturer](https://longbridge.com/en/news/296285939.md)
- [13:22 ET/C O R R E C T I O N -- Rayence/](https://longbridge.com/en/news/296256530.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**